Stock Rich List
Nasdaq: LGND

Ligand Pharmaceuticals insiders

The officers, directors and 10% owners of Ligand Pharmaceuticals Incorporated who hold the most stock, valued at the live LGND price.

$286.94
LGND today −$11.8M (−3.94%)
Market closed. Prices as of Nov 19, 4:04 PM ET
Ranked insiders
12
Their LGND stock
$369M
Market value
$5.74B
Held by ranked insiders
6.42%

Insiders by value of LGND holdings

SEC ownership page
#InsiderRoleSharesValueOf companyOverall rank
1John L. HigginsDirector417,695$120M2.09%1162nd
2Matthew W. FoehrInsider259,986$74.6M1.30%1495th
3Todd C. DavisChief Executive Officer199,513$57.2M1.00%1694th
4Jason AryehDirector110,501$31.7M0.55%3496th
5Matthew E. KorenbergPresident & COO50,777$14.6M0.25%6391st
6Sunil PatelInsider46,198$13.3M0.23%6660th
7John W. KozarichDirector42,122$12.1M0.21%7620th
8Charles S. BerkmanInsider38,191$11.0M0.19%7218th
9Stephen L. SabbaDirector33,629$9.6M0.17%9016th
10Andrew ReardonCLO & Secretary31,854$9.1M0.16%9380th
11Octavio EspinozaChief Financial Officer27,696$7.9M0.14%10427th
12John L. LamattinaDirector26,969$7.7M0.13%9630th

Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Ligand Pharmaceuticals; see each profile for the filing.